Trupanion (NASDAQ:TRUP) Given New $34.00 Price Target at Stifel Nicolaus

Key Points

• Stifel Nicolaus raised its Trupanion price target to $34 from $29 but maintained a “hold” rating; the new target implies 7.48% downside from the prior close.
• Analyst sentiment is mostly neutral: MarketBeat reports a consensus “hold” rating and a $40 average price target.
• Trupanion beat quarterly estimates, reporting EPS of $0.21 versus $0.16 expected and revenue of $405.59 million versus $402.53 million expected.

Trupanion (NASDAQ:TRUP - Get Free Report) had its price target boosted by analysts at Stifel Nicolaus from $29.00 to $34.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage presently has a "hold" rating on the financial services provider's stock. Stifel Nicolaus's price target points to a potential downside of 7.48% from the company's previous close.

Several other analysts have also commented on the company. Atlantic Securities set a $42.00 price objective on Trupanion in a report on Wednesday, July 15th. Cantor Fitzgerald increased their target price on Trupanion from $30.00 to $33.00 and gave the company a "neutral" rating in a report on Monday. Wall Street Zen raised Trupanion from a "hold" rating to a "buy" rating in a research report on Saturday. Piper Sandler downgraded Trupanion from an "overweight" rating to a "neutral" rating and cut their price target for the company from $45.00 to $32.00 in a research note on Wednesday, August 26th. Finally, Weiss Ratings upgraded Trupanion from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, September 29th. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat.com, Trupanion presently has a consensus rating of "Hold" and a consensus price target of $40.00.

Trupanion Stock Performance

NASDAQ:TRUP opened at $36.75 on Monday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.24. Trupanion has a 12 month low of $21.16 and a 12 month high of $46.98. The company has a market cap of $1.59 billion, a PE ratio of 60.25, a price-to-earnings-growth ratio of 2.16 and a beta of 1.27. The company has a 50 day simple moving average of $27.14 and a two-hundred day simple moving average of $26.69.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The financial services provider reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.05. The firm had revenue of $405.59 million for the quarter, compared to analysts' expectations of $402.53 million. Trupanion had a return on equity of 6.71% and a net margin of 1.71%. During the same period in the prior year, the firm earned $0.13 EPS. Research analysts forecast that Trupanion will post 0.64 earnings per share for the current year.

Insiders Place Their Bets

In other Trupanion news, COO John Gallagher sold 3,604 shares of the stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $29.70, for a total value of $107,038.80. Following the transaction, the chief operating officer directly owned 33,742 shares in the company, valued at approximately $1,002,137.40. This trade represents a 9.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Fawwad Qureshi sold 6,111 shares of Trupanion stock in a transaction on Wednesday, August 26th. The stock was sold at an average price of $30.01, for a total transaction of $183,391.11. Following the transaction, the chief financial officer owned 4,230 shares in the company, valued at $126,942.30. This represents a 59.09% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 14,046 shares of company stock worth $407,743. Company insiders own 5.58% of the company's stock.

Hedge Funds Weigh In On Trupanion

A number of institutional investors have recently bought and sold shares of TRUP. Fifth Third Bancorp lifted its position in Trupanion by 4.0% during the third quarter. Fifth Third Bancorp now owns 7,772 shares of the financial services provider's stock valued at $182,000 after purchasing an additional 302 shares in the last quarter. Yousif Capital Management LLC grew its holdings in Trupanion by 4.0% during the third quarter. Yousif Capital Management LLC now owns 9,328 shares of the financial services provider's stock valued at $218,000 after purchasing an additional 356 shares during the period. Illinois Municipal Retirement Fund increased its position in Trupanion by 2.3% in the first quarter. Illinois Municipal Retirement Fund now owns 17,819 shares of the financial services provider's stock worth $456,000 after buying an additional 406 shares in the last quarter. Squarepoint Ops LLC increased its position in Trupanion by 0.7% in the second quarter. Squarepoint Ops LLC now owns 71,382 shares of the financial services provider's stock worth $1,768,000 after buying an additional 482 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund increased its position in Trupanion by 7.7% in the third quarter. Oregon Public Employees Retirement Fund now owns 8,359 shares of the financial services provider's stock worth $195,000 after buying an additional 600 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc is a pet insurance company that provides medical insurance coverage for cats and dogs. Its products are designed to help pet owners manage the cost of veterinary care, including coverage for eligible illnesses, injuries and other qualifying medical conditions, subject to the terms of each policy.

The company offers subscription-based pet insurance through the Trupanion brand, with coverage generally intended for ongoing veterinary expenses rather than routine or preventive care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.